REGN-COV2 treatment for COVID-19 patients in NM

Casirivimab and imdevimab (REGN-COV2), which is produced by Regeneron Pharmaceuticals, should be used for outpatient treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 88 pounds) as soon as possible...

COVID-19 Frequently Asked Questions

This document outlines a series of responses to COVID-19 frequently asked questions, including information about finding New Mexico COVID-19 cases by county, risk of transmission in certain settings (e.g. dining, gyms), and COVID-19 deaths. Download this...